CNBX PHARMACEUTICALS INC. Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
CNBX PHARMACEUTICALS INC. (CNBX) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of -$541.39 thousand for the 12-month period ending 2015-08-31, per its 10-K filed 2016-01-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2016-01-07
- CNBX PHARMACEUTICALS INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2015 was -$541.39K.
- CNBX PHARMACEUTICALS INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2014 was -$219.14K.
- CNBX PHARMACEUTICALS INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2013 was -$56.40K.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|
| 2015-08-31 | -$541.39K 10-K · filed 2016-01-07 |
| 2014-08-31 | -$219.14K 10-K · filed 2016-01-07 |
| 2013-08-31 | -$56.40K 10-K/A · filed 2015-10-23 |